Detalhe da pesquisa
1.
Trastuzumab cardiotoxicity in HER2-positive breast cancer patients in tertiary health care center, sultanate of Oman.
J Oncol Pharm Pract
; 27(2): 312-321, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32340535